Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-03

Clinical Trial Update: Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye [Phase 4]

View source ↗

Summary

Phase 4 trial comparing standard carboxymethylcellulose artificial tears to the same solution with PURITE preservative in patients with dry eye symptoms; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carboxymethylcellulose 0.5% (carboxymethylcellulose)
  • Stabilized oxychlorocomplex (PURITE) 0.005% (stabilized oxychlorocomplex)

Snippet

Sponsor: Chulalongkorn University | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED